Pay in 4 interest-free payments of $5.01 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
Negative side effects may include a paradoxical decrease in energy levels (most likely due to detoxification from methylation) or slight pain at the injection site which diminishes over 5-10 days
Here, we provide experimental evidence to demonstrate that T3 has an insulinotropic effect by acting on the GLP-1 production
& Levine, S
Research-grade specs Components: GHK-Cu (50 mg) + BPC-157 (10 mg) + TB-500 (10 mg) + KPV (10 mg) Total strength: 80 mg per vial Format: Lyophilized powder, single-vial blend Pathways studied: Matrix remodelling (GHK-Cu), cell migration (BPC-157, TB-500), cytokine signalling (KPV) Studied applications Multi-pathway combination research Comparative single-compound vs combination studies Receptor and cytokine pathway interaction research Copper-peptide and tripeptide comparative research Quality & trust 99% HPLC purity, third-party tested Mass spectrometry identity confirmation LAL endotoxin testing on every batch Batch-specific Certificate of Analysis included cGMP manufactured in Dallas, Texas (USA) USA same-day shipping (orders before 2pm CT M-F) Free domestic shipping on orders over $200 Storage & handling Store lyophilized vials refrigerated at 28C, protected from light and heat Reconstitute with bacteriostatic water
Conclusion GLP drugs represent a major advancement in the management of obesity and cardiovascular health in addition to the management of type 2 diabetes, for which they were originally developed
US$ 21.37
US$ 21.33
US$ 29.04
US$ 25.34
